Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
INZY Inozyme Pharma
- 3.030
- +0.050+1.68%
Close Dec 13 16:00 ET
- 2.990
- -0.040-1.32%
Post 20:01 ET
194.65MMarket Cap-1.95P/E (TTM)
3.100High2.810Low809.62KVolume2.980Open2.980Pre Close2.40MTurnover2.48%Turnover RatioLossP/E (Static)64.24MShares7.79552wk High2.35P/B98.75MFloat Cap2.38552wk Low--Dividend TTM32.59MShs Float31.650Historical High--Div YieldTTM9.73%Amplitude0.991Historical Low2.961Avg Price1Lot Size
Inozyme Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 37.50%24.85M | 68.75%27.67M | 32.53%24.35M | 10.15%75.65M | 16.77%22.81M | 6.87%18.07M | 6.52%16.39M | 9.09%18.37M | 21.24%68.68M | 4.14%19.53M |
| Selling and administrative expenses | 4.82%4.96M | 24.94%5.91M | -19.63%5.23M | -0.13%20.8M | -15.29%4.83M | 0.25%4.73M | -12.18%4.73M | 29.59%6.51M | 10.04%20.83M | 9.41%5.7M |
| -General and administrative expense | 4.82%4.96M | 24.94%5.91M | -19.63%5.23M | -0.13%20.8M | -15.29%4.83M | 0.25%4.73M | -12.18%4.73M | 29.59%6.51M | 10.04%20.83M | 9.41%5.7M |
| Research and development costs | 49.09%19.89M | 86.51%21.76M | 61.18%19.11M | 14.63%54.85M | 29.96%17.98M | 9.43%13.34M | 16.58%11.67M | 0.36%11.86M | 26.85%47.85M | 2.11%13.84M |
| Operating profit | -37.50%-24.85M | -68.75%-27.67M | -32.53%-24.35M | -10.15%-75.65M | -16.77%-22.81M | -6.87%-18.07M | -6.52%-16.39M | -9.09%-18.37M | -21.24%-68.68M | -4.14%-19.53M |
| Net non-operating interest income expense | -74.44%362K | -24.31%635K | 5.01%1.05M | 133.01%4.5M | 53.37%1.25M | 92.13%1.42M | 161.37%839K | 1,565.00%999K | 816.11%1.93M | 1,795.35%815K |
| Non-operating interest income | -24.95%1.78M | 26.09%2.03M | 78.90%2.37M | 257.04%7.84M | 135.00%2.53M | 221.44%2.37M | 401.56%1.61M | 2,111.67%1.33M | 940.28%2.2M | 2,404.65%1.08M |
| Non-operating interest expense | 48.58%1.42M | 80.93%1.4M | 303.96%1.33M | 1,172.14%3.33M | --1.28M | --953K | --771K | --328K | --262K | ---- |
| Other net income (expense) | -505.00%-81K | 89.29%-3K | -50.00%-51K | 91.22%-28K | -91.95%14K | 110.15%20K | 85.34%-28K | 67.62%-34K | -68.78%-319K | 535.00%174K |
| Other non- operating income (expenses) | -505.00%-81K | 89.29%-3K | -50.00%-51K | 91.22%-28K | -91.95%14K | 110.15%20K | 85.34%-28K | 67.62%-34K | -68.78%-319K | 535.00%174K |
| Income before tax | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M | -18.43%-67.06M | 1.12%-18.54M |
| Income tax | ||||||||||
| Net income | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M | -18.43%-67.06M | 1.12%-18.54M |
| Net income continuous Operations | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M | -18.43%-67.06M | 1.12%-18.54M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M | -18.43%-67.06M | 1.12%-18.54M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M | -18.43%-67.06M | 1.12%-18.54M |
| Basic earnings per share | -34.48%-0.39 | -25.71%-0.44 | 5.00%-0.38 | 23.03%-1.37 | 16.67%-0.35 | 23.68%-0.29 | 7.89%-0.35 | 43.66%-0.4 | 0.00%-1.78 | -147.06%-0.42 |
| Diluted earnings per share | -34.48%-0.39 | -25.71%-0.44 | 5.00%-0.38 | 23.03%-1.37 | 16.67%-0.35 | 23.68%-0.29 | 7.89%-0.35 | 43.66%-0.4 | 0.00%-1.78 | -147.06%-0.42 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.